BIRD-C is an acronym for Biotech Innovation Research Development & Consulting and has developed the innovative platform technology, which is based on the Bacterial Ghosts (BGs) through many years of scientific research. Bacterial Ghosts are empty, non-living envelopes, perfectly mimicking the Gram-negative bacteria from which they are derived. Due to BIRD-C’s proprietary production process, Bacterial Ghosts retain all the natural surface structures of the bacteria.
R&D:Vaccine development based on Bacterial Ghosts (BGs) against infectious diseases and tumor treatment. BGs are empty, non-living bacterial envelopes of Gram-negative bacteria.
Dr. Bohrgasse 2-8/14/1
1030 Vienna
Vienna
Contact: Werner Lubitz (CEO)
Telephone: +43 (1) 8906611
Email: werner.lubitz@bird-c.at
Website